Sanibel Captiva Trust Company Inc. Purchases 2,272 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Sanibel Captiva Trust Company Inc. grew its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 3.4% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 69,016 shares of the healthcare conglomerate's stock after buying an additional 2,272 shares during the period. UnitedHealth Group makes up about 1.1% of Sanibel Captiva Trust Company Inc.'s investment portfolio, making the stock its 22nd largest holding. Sanibel Captiva Trust Company Inc.'s holdings in UnitedHealth Group were worth $34,912,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in UNH. State Street Corp lifted its holdings in shares of UnitedHealth Group by 1.3% during the third quarter. State Street Corp now owns 45,540,102 shares of the healthcare conglomerate's stock valued at $26,626,387,000 after purchasing an additional 563,554 shares in the last quarter. Geode Capital Management LLC boosted its holdings in shares of UnitedHealth Group by 1.6% during the 3rd quarter. Geode Capital Management LLC now owns 19,636,704 shares of the healthcare conglomerate's stock valued at $11,440,133,000 after acquiring an additional 318,039 shares during the last quarter. Franklin Resources Inc. grew its holdings in shares of UnitedHealth Group by 2.5% in the third quarter. Franklin Resources Inc. now owns 8,061,916 shares of the healthcare conglomerate's stock worth $4,884,019,000 after acquiring an additional 193,800 shares during the period. International Assets Investment Management LLC boosted its position in shares of UnitedHealth Group by 78,814.4% in the third quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate's stock worth $3,096,896,000 after purchasing an additional 5,290,025 shares during the period. Finally, Ameriprise Financial Inc. boosted its holdings in UnitedHealth Group by 0.6% in the 2nd quarter. Ameriprise Financial Inc. now owns 3,772,487 shares of the healthcare conglomerate's stock worth $1,920,039,000 after buying an additional 21,149 shares during the period. Institutional investors own 87.86% of the company's stock.

UnitedHealth Group Trading Down 0.1 %

Shares of NYSE UNH traded down $0.56 during mid-day trading on Friday, reaching $510.03. The company had a trading volume of 7,462,712 shares, compared to its average volume of 5,104,531. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73. The business's 50-day moving average is $549.37 and its 200-day moving average is $563.18. The stock has a market cap of $469.37 billion, a price-to-earnings ratio of 33.23, a price-to-earnings-growth ratio of 1.42 and a beta of 0.62. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. The firm had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The company's revenue was up 6.8% on a year-over-year basis. During the same quarter in the previous year, the firm posted $5.83 earnings per share. Equities analysts expect that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were paid a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.65%. UnitedHealth Group's dividend payout ratio is presently 54.72%.

Analysts Set New Price Targets

Several research firms recently issued reports on UNH. Stephens increased their target price on UnitedHealth Group from $605.00 to $675.00 and gave the stock an "overweight" rating in a research report on Thursday, December 5th. StockNews.com cut shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a research note on Wednesday. Barclays reduced their target price on UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating on the stock in a report on Friday. Oppenheimer lifted their price objective on UnitedHealth Group from $610.00 to $640.00 and gave the stock an "outperform" rating in a research note on Friday, December 6th. Finally, Royal Bank of Canada reduced their price target on shares of UnitedHealth Group from $615.00 to $595.00 and set an "outperform" rating on the stock in a research report on Wednesday, October 16th. Two investment analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, the company has a consensus rating of "Buy" and an average price target of $627.74.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.